Header Logo

Connection

CHRIS AMOS to Risk Assessment

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Risk Assessment.
CHRIS AMOS
Connection Strength
1.119
Risk Assessment
  1. Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting. Oral Oncol. 2020 03; 102:104440.
    View in: PubMed
    Score: 0.080
  2. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Lancet Respir Med. 2019 10; 7(10):881-891.
    View in: PubMed
    Score: 0.078
  3. Aspirin, NSAIDs, and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2019 03; 28(3):555-562.
    View in: PubMed
    Score: 0.075
  4. Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1370-1380.
    View in: PubMed
    Score: 0.068
  5. Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. J Invest Dermatol. 2017 08; 137(8):1792-1795.
    View in: PubMed
    Score: 0.067
  6. The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers. Cancer Epidemiol Biomarkers Prev. 2017 01; 26(1):126-135.
    View in: PubMed
    Score: 0.065
  7. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010 Feb 15; 16(4):1331-9.
    View in: PubMed
    Score: 0.041
  8. Building a predictive breast cancer risk model. AMIA Annu Symp Proc. 2007 Oct 11; 995.
    View in: PubMed
    Score: 0.035
  9. Assessing BRCA carrier probabilities in extended families. J Clin Oncol. 2006 Jan 20; 24(3):354-60.
    View in: PubMed
    Score: 0.031
  10. An informatics tool to assess colon cancer risk. AMIA Annu Symp Proc. 2005; 998.
    View in: PubMed
    Score: 0.029
  11. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
    View in: PubMed
    Score: 0.028
  12. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clin Gastroenterol Hepatol. 2024 Sep; 22(9):1858-1866.e4.
    View in: PubMed
    Score: 0.027
  13. What is the additive value of nutritional deficiency to VA-FI in the risk assessment for heart failure patients? J Nutr Health Aging. 2024 Jul; 28(7):100253.
    View in: PubMed
    Score: 0.027
  14. Thrombosis risk prediction in lymphoma patients: A multi-institutional, retrospective model development and validation study. Am J Hematol. 2024 07; 99(7):1230-1239.
    View in: PubMed
    Score: 0.027
  15. Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification. Genome Med. 2024 02 05; 16(1):22.
    View in: PubMed
    Score: 0.027
  16. Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. J Natl Cancer Inst. 2023 09 07; 115(9):1050-1059.
    View in: PubMed
    Score: 0.026
  17. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3.
    View in: PubMed
    Score: 0.025
  18. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309.
    View in: PubMed
    Score: 0.025
  19. Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems. J Clin Oncol. 2023 06 01; 41(16):2926-2938.
    View in: PubMed
    Score: 0.025
  20. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 2021 03 15; 81(6):1607-1615.
    View in: PubMed
    Score: 0.022
  21. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nat Commun. 2020 07 03; 11(1):3353.
    View in: PubMed
    Score: 0.021
  22. Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective. Cancer Res. 2020 01 15; 80(2):347-353.
    View in: PubMed
    Score: 0.020
  23. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017 11 02; 551(7678):92-94.
    View in: PubMed
    Score: 0.017
  24. Risk of Metachronous High-Risk Adenomas and Large Serrated Polyps in Individuals With Serrated Polyps on Index Colonoscopy: Data From the New Hampshire Colonoscopy Registry. Gastroenterology. 2018 01; 154(1):117-127.e2.
    View in: PubMed
    Score: 0.017
  25. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2017 Nov; 15(11):1791-1799.
    View in: PubMed
    Score: 0.017
  26. Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncol. 2017 May 01; 3(5):636-651.
    View in: PubMed
    Score: 0.017
  27. Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. J Invest Dermatol. 2015 Sep; 135(9):2266-2272.
    View in: PubMed
    Score: 0.015
  28. Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study. J Clin Oncol. 2014 Apr 20; 32(12):1249-55.
    View in: PubMed
    Score: 0.014
  29. Assessing the added value of breast tumor markers in genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2012 May; 133(1):347-55.
    View in: PubMed
    Score: 0.012
  30. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst. 2011 Sep 07; 103(17):1342-6.
    View in: PubMed
    Score: 0.011
  31. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 Jul 07; 102(13):959-71.
    View in: PubMed
    Score: 0.010
  32. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst. 2009 Dec 16; 101(24):1731-2; author reply 1732.
    View in: PubMed
    Score: 0.010
  33. Health and lifestyle behaviors among persons at risk of Lynch syndrome. Cancer Causes Control. 2010 Apr; 21(4):513-21.
    View in: PubMed
    Score: 0.010
  34. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. J Clin Gastroenterol. 2009 May-Jun; 43(5):444-7.
    View in: PubMed
    Score: 0.010
  35. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008 Nov 05; 100(21):1552-6.
    View in: PubMed
    Score: 0.009
  36. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008 Sep; 1(4):250-4.
    View in: PubMed
    Score: 0.009
  37. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol. 2007 Nov 01; 25(31):4974-81.
    View in: PubMed
    Score: 0.009
  38. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007 May 02; 99(9):715-26.
    View in: PubMed
    Score: 0.008
  39. Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98.
    View in: PubMed
    Score: 0.008
  40. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71.
    View in: PubMed
    Score: 0.008
  41. Strategies to improve healthcare websites. AMIA Annu Symp Proc. 2006; 969.
    View in: PubMed
    Score: 0.008
  42. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
    View in: PubMed
    Score: 0.008
  43. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003 Aug 20; 95(16):1211-8.
    View in: PubMed
    Score: 0.006
  44. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Hum Genet. 2003 Aug; 113(3):238-43.
    View in: PubMed
    Score: 0.006
  45. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J Natl Cancer Inst. 2003 Feb 19; 95(4):308-15.
    View in: PubMed
    Score: 0.006
  46. Segregation analysis of cancer in families of glioma patients. Genet Epidemiol. 2001 Feb; 20(2):258-70.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.